VASOTEC Drug Patent Profile
✉ Email this page to a colleague
When do Vasotec patents expire, and when can generic versions of Vasotec launch?
Vasotec is a drug marketed by Biovail Labs Intl and Bausch and is included in two NDAs.
The generic ingredient in VASOTEC is enalapril maleate. There are twenty-seven drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vasotec
A generic version of VASOTEC was approved as enalapril maleate by HERITAGE PHARMA on August 22nd, 2000.
Summary for VASOTEC
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 83 |
Clinical Trials: | 8 |
Patent Applications: | 2,785 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VASOTEC |
What excipients (inactive ingredients) are in VASOTEC? | VASOTEC excipients list |
DailyMed Link: | VASOTEC at DailyMed |
Recent Clinical Trials for VASOTEC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Novartis Pharmaceuticals | Phase 4 |
Brigham and Women's Hospital | Phase 4 |
University of Wisconsin, Madison | Phase 4 |
Pharmacology for VASOTEC
Drug Class | Angiotensin Converting Enzyme Inhibitor |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Physiological Effect | Decreased Blood Pressure |
US Patents and Regulatory Information for VASOTEC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biovail Labs Intl | VASOTEC | enalaprilat | INJECTABLE;INJECTION | 019309-001 | Feb 9, 1988 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-002 | Dec 24, 1985 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-005 | Jul 26, 1988 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-001 | Dec 24, 1985 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-003 | Dec 24, 1985 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VASOTEC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-001 | Dec 24, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-002 | Dec 24, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-003 | Dec 24, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Biovail Labs Intl | VASOTEC | enalaprilat | INJECTABLE;INJECTION | 019309-001 | Feb 9, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Bausch | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-005 | Jul 26, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for VASOTEC
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Proveca Pharma Limited | Aqumeldi | Enalapril maleate | EMEA/H/C/005731 Treatment of heart failure. |
Authorised | no | no | no | 2023-11-15 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for VASOTEC
See the table below for patents covering VASOTEC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Bulgaria | 39467 | METHOD FOR PREPARING OF CARBOXYALKYL DIPEPTIDES | ⤷ Try a Trial |
South Korea | 840005083 | ⤷ Try a Trial | |
Finland | 68405 | ⤷ Try a Trial | |
Lithuania | 2158 | ⤷ Try a Trial | |
Denmark | 523579 | ⤷ Try a Trial | |
Czechoslovakia | 237327 | METHOD OF PREPARATION OF CARBOXYALKYL DIPEPTIDE | ⤷ Try a Trial |
Yugoslavia | 300079 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |